Delivery Order SPE2DB20D1110-SPE2DB23FK15W
- Not listed
- This federal contract award, valued at $1,934.47, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract provides for the delivery of BRIDION 200 MG/2 ML VIAL 2ML, a pharmaceutical product, with a completion date of November 2, 2023. The contract is a Firm Fixed Price Delivery Order, and there is no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, valued at $14,817.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of BRIDION 200 MG/2 ML VIAL 2ML, a pharmaceutical product, and has an ultimate completion date of May 4, 2023. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and was awarded on May 3, 2023 without any set-aside designations. Amerisourcebergen Drug Corp, a major pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $6,197.11, is for the delivery of 4558300264 - BRIDION 200 MG/2 ML VIAL 2ML, a pharmaceutical product. The contract has a firm fixed price pricing type and a completion date of September 1, 2022. This appears to be a delivery order under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at $7,326.78, is for the delivery of BRIDION 200 MG/2 ML VIAL 2ML, a medical product. The contract has a completion date of April 29, 2024 and is a Firm Fixed Price Delivery Order. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, valued at $5,620.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of BRIDION 200 MG/2 ML VIAL 2ML, a pharmaceutical product, to support military healthcare programs. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is December 1, 2023. This award is not associated with a set-aside designation, indicating open...
- This federal contract award valued at $30,330.98 was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of BRIDION 200 MG/2 ML VIAL 2ML, a pharmaceutical product, with a completion date of September 27, 2023. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $9,269.71, is for the delivery of BRIDION 200 MG/2 ML VIAL 2ML medical supplies. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) between Cencora, Inc. (the parent company of Amerisourcebergen Drug Corp) and the DLA Troop Support Medical, valued at up to $999,999,999.00...
- This federal contract award, valued at $5,044.31, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order for BRIDION 200 MG/2 ML VIAL 2ML, a medical product, with an ultimate completion date of May 4, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also registered in the System for Award Management (SAM.gov). This contract is not designated as a...
- This federal contract award, valued at $13,865.93, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of BRIDION 200 MG/2 ML VIAL 2ML, a pharmaceutical product, and has a performance period ending on September 27, 2023. The contract was awarded as a delivery order without any set-aside designation, indicating it was competed on an open-market basis. Amerisourcebergen Drug Corp is a major pharmaceutical...
- This federal contract award, valued at $2,683.05, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of BRIDION 200 MG/2 ML VIAL 2ML medical supplies and has an ultimate completion date of April 29, 2024. The contract is not designated with any set-aside requirements, indicating an open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- SPE2DB20D1110Indefinite Delivery Contract
- SPE2DB20D1110-SPE2DB23FK15WDelivery Order
This federal contract award, valued at $2,439.16, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4560784492 - BRIDION 200 MG/2 ML VIAL 2ML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of May 2, 2023. The contract was awarded on May 1, 2023 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 5/1/23 |